Cancer Research UK scientists are the first to use an efficient new screening strategy to identify gene faults in tumour cells that are possible drug targets for the most common form of lung cancer, according to new research published in PNAS.
The team found three key gene faults that lead to the production of overactive proteins, sending signals telling the cells to grow out of control. Importantly, these proteins are potential targets for precision cancer drugs that block specific molecules in tumor cells.
Read the full article here: Genetic screen finds new treatment targets for lung cancer
